Vasant Narasimkhan Last position: Chief executive officer (Novartis Int AG)Views0+0 last weekSubscribers0+0 last weekRelated events0+0 last weekWatchExportPerson's profile exportAnalyticsPerson's popularity and news analyticsNewsAll updates related to this person inLast 24h3 days7 days30 daysConnections TreeVarious connection types built via mentions in articlesLast 24h3 days7 days30 daysConnection typesPersonsCompaniesPolitical partiesGovernment AgenciesGeographical objectsOrganizationsEventsLawsProductsTechnologiesShareMedia Score: Low0Related events+0 last weekChief executive officerNovartis Int AGMedia Score: LowChief executive officerNovartis Int AG47years oldBornAugust 26, 1976PittsburghRelationship status: He is marriedConnectionsno dataNewsConnections Tree
Finances & Markets1/17/2024MediaPeopleProductsCompaniesGeography47 secFinances & MarketsNovartis Int AG allocated business generics and bioanalogues of SandozPRIME10/4/2023CompaniesGeographyPeople30 secOtherNovartis Int AG declared aspiration to become most expensive pharmaceutical company in the worldPRIME2/1/2023PeopleGeographyCompanies38 secLarge businessNovartis Int AG will sell the rights for five preparations from diseases of eyesPharmaceutical messenger12/16/2022PeopleGeographyCompanies1 minLarge businessПодразделение швейцарской Novartis станет крупнейшей компанией-производителем дженериков8/25/2022PeopleCompaniesGeography32 secLarge businessThe Swiss Novartis Int AG creates the largest in Europe the producer of genericsTo Kommersantj.R8/25/2022PeopleGeographyCompanies1 min
Large businessNovartis Int AG will reduce 8 thousand workplaces worldwidePharmaceutical messenger6/29/2022PeopleMediaCompaniesGeography59 secLarge businessNovartis Int AG in the I quarter showed growth of the income at the expense of the division of SandozPharmaceutical messenger4/26/2022CompaniesPeople1.2 minLarge businessThe operating profit of Novartis Int AG in a year grew by 13%Pharmaceutical messenger2/3/2022CompaniesMediaGeographyPeople1.6 minLarge businessApplicants for purchase divisions of Novartis Int AG by Sandoz] are callePharmaceutical messenger2/2/2022CompaniesMediaPeople1.3 minLarge businessThe net profit of Novartis Int AG in 2021 grew three times - to $24 billionFinam2/2/2022PeopleGeographyCompanies47 secLarge businessApplicants for purchase the producer of Sandoz generics] are calleBusiness weekly "Company"2/2/2022MediaGeographyCompaniesPeople1.5 min
Trending EventsMost discussed today57International forum of business and power "Week of the Russian Retail"Rating: 13Mention frequency13ConnectionsOrganizations27People16Places13Technologies2Events1
Finances & MarketsSales Novartis Int AG in the III quarter grew by 5%Pharmaceutical messenger10/29/2021GeographyCompaniesPeople1.3 minFinances & MarketsNovartis Int AG surpassed expectations of financial analysts in the II quarterPharmaceutical messenger7/21/2021CompaniesPeople1.4 minLarge businessThe net profit of Novartis Int AG in 1 half-year grew by 23% - to $5 billionFinam7/21/2021PeopleGeographyCompanies54 secLarge businessAt pharmaceutical companies China weight on the international scene] grewebsite "Rossiyskaya gazeta"4/22/2021CompaniesPeopleMediaGeography2.6 minFinances & MarketsThe profit of Novartis Int AG for the fourth quarter grew by 86%Pharmaceutical messenger1/27/2021PeopleCompaniesGeographyMedia1.2 minLarge businessNovartis Int AG are sold by the enterprise for production substances to the Chinese farmproizvoditelPharmaceutical messenger9/6/2019MediaCompaniesGeographyPeople1.2 min